Certified by Founder Lodge
Arbor Biotechnologies
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $215,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Arbor’s platform employs a diverse set of technologies and techniques – including artifi
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 09 ,2021 | Series B | $215,000,000 | |
| March, 19 ,2025 | Series C | $73,900,000.00 | |
| March, 19 ,2025 | Series C | $73,900,000.00 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CREAO AI | $10,000,000 | (Apr 21, 2026)
TraqCheck | $8,000,000 | (Apr 21, 2026)
Antioch | $8,500,000 | (Apr 21, 2026)
ScreenPoint Medical | $14,000,000 | (Apr 21, 2026)
Ultralight | $9,300,000 | (Apr 21, 2026)
